Format

Send to

Choose Destination
See comment in PubMed Commons below
Theranostics. 2012;2(12):1208-22. doi: 10.7150/thno.4306. Epub 2012 Dec 31.

Advances in ultrasound mediated gene therapy using microbubble contrast agents.

Author information

1
Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.

Abstract

Microbubble ultrasound contrast agents have the potential to dramatically improve gene therapy treatments by enhancing the delivery of therapeutic DNA to malignant tissue. The physical response of microbubbles in an ultrasound field can mechanically perturb blood vessel walls and cell membranes, enhancing drug permeability into malignant tissue. In this review, we discuss literature that provided evidence of specific mechanisms that enhance in vivo gene delivery utilizing microbubble contrast agents, namely their ability to 1) improving cell membrane permeability, 2) modulate vascular permeability, and 3) enhance endocytotic uptake in cells. Additionally, we review novel microbubble vectors that are being developed in order to exploit these mechanisms and deliver higher gene payloads with greater target specificity. Finally, we discuss some future considerations that should be addressed in the development of next-generation microbubbles in order to improve in vivo microbubble gene delivery. Overall, microbubbles are rapidly gaining popularity as efficient gene carriers, and combined with their functionality as imaging contrast agents, they represent powerful theranostic tools for image guided gene therapy applications.

KEYWORDS:

Cavitiation; Sonoporation; Targeted Image-Guided DNA Delivery.

PMID:
23382777
PMCID:
PMC3563148
DOI:
10.7150/thno.4306
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ivyspring International Publisher Icon for PubMed Central
    Loading ...
    Support Center